DARZALEX SC
Google image searchProduct monograph
Active ingredient
daratumumab, 1800 MG/15 ML
DIN: 02502712
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: JANSSEN INC
Date: 12-AUG-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FC — CD38 (Clusters of Differentiation 38) inhibitors (ATC, ATC/DDD)
- L01FC01 — DARATUMUMAB (ATC/DDD)
External Links for Darzalex Sc
Search on Google
Janssen Inc
Go to Janssen website to see drug product details. Sometimes you can find darzalex sc photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.